PubMed

Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.

Rebarber A, Istwan NB, Russo-Stieglitz K, Cleary-Goldman J, Rhea DJ, Stanziano GJ, Saltzman DH.

Diabetes Care. 2007 Sep;30(9):2277-80. Epub 2007 Jun 11.PMID: 17563346 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate.

Ventolini G, Duke J, Po W, Barhan S, Rhea D, Desch C, Istwan N, Stanziano G.

J Reprod Med. 2008 Sep;53(9):667-71.PMID: 18839818 [PubMed - indexed for MEDLINE]Related articles

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.

González-Quintero VH, Istwan NB, Rhea DJ, Smarkusky L, Hoffman MC, Stanziano GJ.

J Matern Fetal Neonatal Med. 2007 Mar;20(3):249-52.PMID: 17437227 [PubMed - indexed for MEDLINE]Related articles

Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.

Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.

Am J Obstet Gynecol. 2008 Oct;199(4):389.e1-4.PMID: 18928983 [PubMed - indexed for MEDLINE]Related articles

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate.

Rebarber A, Ferrara LA, Hanley ML, Istwan NB, Rhea DJ, Stanziano GJ, Saltzman DH.

Am J Obstet Gynecol. 2007 Mar;196(3):224.e1-4.PMID: 17346529 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

How HY, Barton JR, Istwan NB, Rhea DJ, Stanziano GJ.

Am J Obstet Gynecol. 2007 Sep;197(3):260.e1-4.PMID: 17826411 [PubMed - indexed for MEDLINE]Related articles

Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.

Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.

Am J Obstet Gynecol. 2007 Sep;197(3):262.e1-4.PMID: 17826412 [PubMed - indexed for MEDLINE]Related articles

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.

Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1127-31.PMID: 16157124 [PubMed - indexed for MEDLINE]Related articles

Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.

Petrini JR, Callaghan WM, Klebanoff M, Green NS, Lackritz EM, Howse JL, Schwarz RH, Damus K.

Obstet Gynecol. 2005 Feb;105(2):267-72.PMID: 15684150 [PubMed - indexed for MEDLINE]Related articles

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2003 Jun 12;348(24):2379-85. Erratum in: N Engl J Med. 2003 Sep 25;349(13):1299. PMID: 12802023 [PubMed - indexed for MEDLINE]Related articlesFree article

Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance.

Rittenberg C, Newman RB, Istwan NB, Rhea DJ, Stanziano GJ.

J Reprod Med. 2009 Feb;54(2):47-52.PMID: 19301566 [PubMed - indexed for MEDLINE]Related articles

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.

Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2007 Aug 2;357(5):454-61.PMID: 17671253 [PubMed - indexed for MEDLINE]Related articlesFree article

17 hydroxyprogesterone for the prevention of preterm delivery.

Meis PJ; Society for Maternal-Fetal Medicine.

Obstet Gynecol. 2005 May;105(5 Pt 1):1128-35. Review.PMID: 15863556 [PubMed - indexed for MEDLINE]Related articles

Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.

Waters TP, Schultz BA, Mercer BM, Catalano PM.

Obstet Gynecol. 2009 Jul;114(1):45-9.PMID: 19546757 [PubMed - indexed for MEDLINE]Related articles

Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.

Sanchez-Ramos L, Kaunitz AM, Delke I.

Obstet Gynecol. 2005 Feb;105(2):273-9. Review.PMID: 15684151 [PubMed - indexed for MEDLINE]Related articles

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.

Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Meis PJ, Spong CY, Dombrowski M, Sibai B, Varner MW, Iams JD, Mercer BM, Carpenter MW, Lo J, Ramin SM, O'Sullivan MJ, Miodovnik M, Conway D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Am J Obstet Gynecol. 2009 Oct;201(4):392.e1-5. Epub 2009 Aug 29.PMID: 19716543 [PubMed - indexed for MEDLINE]Related articles

Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery.

Sibai B, Meis PJ, Klebanoff M, Dombrowski MP, Weiner SJ, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM Jr, Peaceman AM, Gabbe S; Maternal Fetal Medicine Units Network of the National Institute of Child Health and Human Development.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1181-6.PMID: 16157134 [PubMed - indexed for MEDLINE]Related articles

The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.

Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, Saltzman DH.

Am J Perinatol. 2008 May;25(5):271-5. Epub 2008 Apr 9.PMID: 18401840 [PubMed - indexed for MEDLINE]Related articles

Progesterone does not prevent preterm births in women with twins.

Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, Morrison JC.

South Med J. 2009 Sep;102(9):900-4.PMID: 19668021 [PubMed - indexed for MEDLINE]Related articles

Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate.

Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A.

Am J Obstet Gynecol. 2007 May;196(5):453.e1-4; discussion 421.PMID: 17466698 [PubMed - indexed for MEDLINE]Related articles